Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches.
- Published In:
- Pharmaceutical research, 42(5), 805-818 (2025)
- Authors:
- De Groot, Anne S, Mattei, Aimee, Gabriel, Benjamin, Calderini, Jennifer, Roberts, Brian J, Lelias, Sandra, McAllister, Mitchell, Boyle, Christine, Martin, William, Richard, Guilhem
- Database ID:
- RPEP-10652
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10652APA
De Groot, Anne S; Mattei, Aimee; Gabriel, Benjamin; Calderini, Jennifer; Roberts, Brian J; Lelias, Sandra; McAllister, Mitchell; Boyle, Christine; Martin, William; Richard, Guilhem. (2025). Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches.. Pharmaceutical research, 42(5), 805-818. https://doi.org/10.1007/s11095-025-03843-1
MLA
De Groot, Anne S, et al. "Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches.." Pharmaceutical research, 2025. https://doi.org/10.1007/s11095-025-03843-1
RethinkPeptides
RethinkPeptides Research Database. "Immunogenicity of Generic Peptide Impurities: Current Orthog..." RPEP-10652. Retrieved from https://rethinkpeptides.com/research/de-2025-immunogenicity-of-generic-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.